SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-17-009293
Filing Date
2017-12-11
Accepted
2017-12-11 17:30:34
Documents
7
Period of Report
2017-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 51264
2 EX-99.1 ex-99d1.htm EX-99.1 22545
3 EX-99.2 ex-99d2.htm EX-99.2 23293
4 EX-99.3 ex-99d3.htm EX-99.3 26941
5 GRAPHIC ex-99d1g001.jpg GRAPHIC 8672
6 GRAPHIC ex-99d2g001.jpg GRAPHIC 8672
7 GRAPHIC ex-99d3g001.jpg GRAPHIC 8672
  Complete submission text file 0001558370-17-009293.txt   161475
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 171250404
SIC: 2834 Pharmaceutical Preparations